The company previously recalled hundreds of lots of the hypertension drug after discovering the presence of a carcinogen.
The recall includes five additional lots of losartan potassium tablets and losartan potassium hydrochlorothiazide tablets after trace amounts of N-Methylnitrosobutyric acid were detected.
Losartan tablets are used to treat left ventricular hypertrophy and nephropathy in Type 2 diabetes patients.
Torrent warned that patients currently taking losartan should continue taking their medication, as the risk of damage to the patients’ health may be higher if they don’t have an alternative treatment. Patients should contact their physicians about alternative treatment before returning the recalled drug.
Read the full recall notice here.
More articles on pharmacy:
Carcinogen concerns prompt Sandoz to halt global distribution of heartburn drug
DEA raids some West Coast Kaiser Permanente pharmacies
California biotech files for bankruptcy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
